Lisinopril and Therapeutic response increased - a phase IV clinical study of FDA data

Summary:

Therapeutic response increased is reported as a side effect among people who take Lisinopril (lisinopril), especially for people who are female, 60+ old, also take Pantoprazole, and have Pain.

The phase IV clinical study analyzes which people have Therapeutic response increased when taking Lisinopril. It is created by eHealthMe based on reports of 343,814 people who have side effects when taking Lisinopril from the FDA, and is updated regularly.

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,654 Lisinopril users. Check the latest studies of Lisinopril.

What is Therapeutic response increased?

Therapeutic response increased (high preventive response) is found to be associated with 131 drugs and 297 conditions by eHealthMe. Check the latest studies of Therapeutic response increased.

On Jul, 18, 2026

343,814 people reported to have side effects when taking Lisinopril.
Among them, 20 people (0.01%) have Therapeutic response increased.

Could Lisinopril cause Therapeutic response increased?

Among these 20 people:

What is the gender of people who have Therapeutic response increased when taking Lisinopril? *

female: 55 %
male: 45 %

What is the age of people who have Therapeutic response increased when taking Lisinopril? *

What are other drugs people take besides Lisinopril? *

What are other side effects people have besides Therapeutic response increased? *

Hypotension (abnormally low blood pressure): 6 people, 30.00%
Nausea (feeling of having an urge to vomit): 6 people, 30.00%
Nosebleed (bleeding from nose): 5 people, 25.00%
Haemorrhagic Anaemia (anaemia due to excessive bleeding): 4 people, 20.00%
Arrhythmias (irregular heartbeat): 4 people, 20.00%
Weight Decreased: 3 people, 15.00%
Drug Ineffective: 3 people, 15.00%
Nausea And Vomiting: 3 people, 15.00%
Dehydration (dryness resulting from the removal of water): 2 people, 10.00%
Delirium (wild excitement): 2 people, 10.00%

What are the existing conditions these people have? *

Pain: 6 people, 30.00%
Diabetic Vascular Disorder (diseases of the blood vessels due to diabetes): 4 people, 20.00%
Insomnia (sleeplessness): 4 people, 20.00%
Cardiac Valve Disease (heart valve disease): 4 people, 20.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 15.00%
Depression: 3 people, 15.00%
Vitamin B1 Deficiency: 2 people, 10.00%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 10.00%
Cardiac Failure: 2 people, 10.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lisinopril and have Therapeutic response increased?

- Check whether Therapeutic response increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lisinopril:

Lisinopril (358,654 reports)

Browse all side effects of Lisinopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Therapeutic response increased:

Therapeutic response increased (131 drugs)

Browse all the conditions that are associated with Therapeutic response increased:

Therapeutic response increased (297 conditions)

Related publications that referenced our studies

Dobrosavljevi? Vukojevi? D, Stojkovi? Filipovi? J, Sjerobabin M, Vukovi? J, Vesi? S, "Lisinopril-induced pemphigus foliaceus in a patient with diabetes mellitus and Kaposi-Juliusberg varicelliform eruption", Serbian Journal of Dermatology and Venerology, 2012 Dec .
Dobrosavljevi? Vukojevi? D, Stojkovi? Filipovi? J, Sjerobabin M, Vukovi? J, Vesi? S, "Lisinopril-induced pemphigus foliaceus in a patient with diabetes mellitus and Kaposi-Juliusberg varicelliform eruption", Serbian Journal of Dermatology and Venerology, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on lisinopril (the active ingredients of Lisinopril) and Lisinopril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.